Judge in PhRMA Drug Price Suit to Rule on HHS Motion to Dismiss

The Biden administration on Tuesday secured a win in litigation over Medicare’s drug price negotiation program by persuading a federal judge to rule on its motion to dismiss the lawsuit from a leading pharmaceutical industry group.

Attorneys on behalf of the Department of Health and Human Services demonstrated “good cause” when they argued the court should modify the existing scheduling order and rule first on whether the groups behind the lawsuit lack standing, wrote Judge Robert Pitman for the US District Court for the Western District of Texas.

The National Infusion Center Association filed the lawsuit in June along with ...